Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 12Phase 1/2 6Phase EARLY_PHASE1 5Phase 1 5Phase 4 2Phase 3 2

Status

Completed 16Recruiting 12Active not recruiting 8Terminated 4Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 405Breast 178Thoracic 162Lymphoid 118Gynecologic 97Other hematologic neoplasm 95Head & Neck 92Genitourinary 75CNS 46Plasma cell 32Dermatologic 28Sarcoma 23Myeloid 21Tumor-Agnostic 20Classical hematology 19Other 10Endocrine 8Other solid neoplasm 6Other neoplasm 4NET 2

Conditions

Pancreatic Neuroendocrine Tumors in MEN1 1Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms 1

Interventions

pembrolizumab 1Temozolomide 1CTAP octapeptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × NET × Clear all
NCT05647954 2022-12-13

A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Taizhou Hanzhong biomedical co. LTD

Phase 3 Unknown
350 enrolled
DermatologicEndocrineNET

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms

NCT02705651 2019-04-08

SANO

Medical University of Vienna

Phase 3 Unknown
180 enrolled
EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors in MEN1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡